nodes	percent_of_prediction	percent_of_DWPC	metapath
Metixene—Protriptyline—ABCB1—adrenal gland cancer	0.0123	0.431	CrCbGaD
Metixene—Maprotiline—ABCB1—adrenal gland cancer	0.00786	0.275	CrCbGaD
Metixene—Promethazine—ABCB1—adrenal gland cancer	0.00428	0.15	CrCbGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00414	0.00427	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00413	0.00425	CbGpPWpGaD
Metixene—CHRM5—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00412	0.00424	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—GNRH1—adrenal gland cancer	0.0041	0.00422	CbGpPWpGaD
Metixene—Quetiapine—ABCB1—adrenal gland cancer	0.00409	0.143	CrCbGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00409	0.00421	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00387	0.00398	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—TSHR—adrenal gland cancer	0.00365	0.00376	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00354	0.00364	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00353	0.00363	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00351	0.00361	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00349	0.0036	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00334	0.00344	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00333	0.00343	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.0033	0.00339	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00316	0.00325	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—TSHR—adrenal gland cancer	0.00315	0.00324	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00312	0.00321	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00303	0.00312	CbGpPWpGaD
Metixene—CHRM4—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00303	0.00312	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00302	0.00311	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00299	0.00308	CbGpPWpGaD
Metixene—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00299	0.00308	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00297	0.00305	CbGpPWpGaD
Metixene—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.0029	0.00299	CbGpPWpGaD
Metixene—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00289	0.00298	CbGpPWpGaD
Metixene—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00286	0.00295	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00284	0.00293	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—GNAS—adrenal gland cancer	0.00272	0.0028	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00269	0.00277	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—GNRHR—adrenal gland cancer	0.00266	0.00274	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00264	0.00272	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00261	0.00268	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00258	0.00266	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00254	0.00262	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00253	0.00261	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00247	0.00254	CbGpPWpGaD
Metixene—CHRM4—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00246	0.00254	CbGpPWpGaD
Metixene—CHRM4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00241	0.00248	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—TSHR—adrenal gland cancer	0.0024	0.00247	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00237	0.00244	CbGpPWpGaD
Metixene—CHRM5—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00236	0.00243	CbGpPWpGaD
Metixene—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.00234	0.0024	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00232	0.00239	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00232	0.00238	CbGpPWpGaD
Metixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00231	0.00237	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—TSHR—adrenal gland cancer	0.0023	0.00237	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00222	0.00229	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—GNAS—adrenal gland cancer	0.00213	0.00219	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—GNRH1—adrenal gland cancer	0.0021	0.00217	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—GNRHR—adrenal gland cancer	0.00207	0.00214	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00206	0.00213	CbGpPWpGaD
Metixene—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00202	0.00207	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.002	0.00206	CbGpPWpGaD
Metixene—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.002	0.00205	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00199	0.00205	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00198	0.00203	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00193	0.00199	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00188	0.00193	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—TSHR—adrenal gland cancer	0.00187	0.00193	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00184	0.00189	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—POMC—adrenal gland cancer	0.00183	0.00189	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00183	0.00188	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00182	0.00187	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00181	0.00187	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00181	0.00187	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00181	0.00186	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00179	0.00185	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00179	0.00184	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00179	0.00184	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00178	0.00184	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00178	0.00183	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00177	0.00182	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00176	0.00181	CbGpPWpGaD
Metixene—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00176	0.00181	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—POMC—adrenal gland cancer	0.00176	0.00181	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00172	0.00177	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00167	0.00171	CbGpPWpGaD
Metixene—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00166	0.00171	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00166	0.00171	CbGpPWpGaD
Metixene—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00166	0.00171	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00165	0.0017	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00164	0.00169	CbGpPWpGaD
Metixene—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00164	0.00169	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00162	0.00167	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00162	0.00167	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00162	0.00167	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00161	0.00166	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00161	0.00166	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.0016	0.00165	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.0016	0.00165	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—GNRH1—adrenal gland cancer	0.00159	0.00164	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00157	0.00161	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00156	0.00161	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00155	0.00159	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00154	0.00159	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00154	0.00158	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00152	0.00157	CbGpPWpGaD
Metixene—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.0015	0.00155	CbGpPWpGaD
Metixene—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.0015	0.00155	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00147	0.00152	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—CDC42—adrenal gland cancer	0.00146	0.00151	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—SPRY2—adrenal gland cancer	0.00146	0.0015	CbGpPWpGaD
Metixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00143	0.00148	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—POMC—adrenal gland cancer	0.00143	0.00147	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TSHR—adrenal gland cancer	0.00142	0.00146	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—CDC42—adrenal gland cancer	0.0014	0.00144	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—GNAS—adrenal gland cancer	0.0014	0.00144	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00139	0.00144	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TSHR—adrenal gland cancer	0.00136	0.0014	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00135	0.00139	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—GNAS—adrenal gland cancer	0.00134	0.00138	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—MEN1—adrenal gland cancer	0.00133	0.00137	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—MEN1—adrenal gland cancer	0.00128	0.00131	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00126	0.00129	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.00124	0.00128	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00124	0.00128	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.00124	0.00127	CbGpPWpGaD
Metixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00124	0.00127	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.00123	0.00127	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.00122	0.00126	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.0012	0.00124	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00116	0.0012	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00116	0.00119	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00115	0.00118	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.00114	0.00117	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.00114	0.00117	CbGpPWpGaD
Metixene—CHRM3—Metabolism—MED12—adrenal gland cancer	0.00112	0.00115	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TSHR—adrenal gland cancer	0.00111	0.00114	CbGpPWpGaD
Metixene—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.0011	0.00113	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.00109	0.00112	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00109	0.00112	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00108	0.00111	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.00107	0.0011	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00107	0.0011	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00107	0.0011	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00106	0.00109	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—MEN1—adrenal gland cancer	0.00104	0.00107	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00104	0.00107	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—POMC—adrenal gland cancer	0.00104	0.00107	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00103	0.00106	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00102	0.00105	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—PRKACA—adrenal gland cancer	0.00102	0.00105	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—POMC—adrenal gland cancer	0.000992	0.00102	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000986	0.00101	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.000983	0.00101	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000982	0.00101	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.000979	0.00101	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—PRKACA—adrenal gland cancer	0.000975	0.001	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000973	0.001	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000969	0.000998	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.000957	0.000985	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.000954	0.000982	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.000944	0.000972	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000942	0.00097	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—POMC—adrenal gland cancer	0.000941	0.000968	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.000939	0.000967	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.00093	0.000957	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—POMC—adrenal gland cancer	0.000901	0.000927	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.000899	0.000926	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.000897	0.000923	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000888	0.000914	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CDC42—adrenal gland cancer	0.000864	0.000889	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—IGF2—adrenal gland cancer	0.000832	0.000857	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CDC42—adrenal gland cancer	0.000827	0.000851	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—GNAS—adrenal gland cancer	0.000825	0.00085	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.000818	0.000843	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.000809	0.000832	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000805	0.000829	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—IGF2—adrenal gland cancer	0.000797	0.000821	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000795	0.000818	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—GNAS—adrenal gland cancer	0.00079	0.000814	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—IGF1R—adrenal gland cancer	0.000771	0.000793	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000734	0.000756	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000698	0.000719	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000696	0.000717	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TERT—adrenal gland cancer	0.000693	0.000713	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000689	0.00071	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000687	0.000707	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000684	0.000705	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000678	0.000698	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000674	0.000694	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	0.000664	0.000683	CbGpPWpGaD
Metixene—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.000663	0.000683	CbGpPWpGaD
Metixene—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.000651	0.00067	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	0.00065	0.000669	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000644	0.000663	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000634	0.000653	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000632	0.000651	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.000628	0.000647	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000626	0.000645	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	0.000603	0.00062	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000582	0.000599	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000581	0.000598	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	0.000577	0.000594	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000575	0.000592	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000561	0.000578	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.00056	0.000576	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000556	0.000573	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	0.000556	0.000572	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000555	0.000571	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000554	0.00057	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000549	0.000565	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	0.000549	0.000565	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000543	0.000559	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000541	0.000557	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	0.000541	0.000557	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000536	0.000551	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	0.000532	0.000548	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000532	0.000547	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	0.000525	0.000541	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000509	0.000524	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	0.000471	0.000484	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000467	0.000481	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000466	0.000479	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000461	0.000475	CbGpPWpGaD
Metixene—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000447	0.00046	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	0.000434	0.000447	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000428	0.000441	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000415	0.000427	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000406	0.000418	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.000405	0.000417	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000401	0.000413	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000397	0.000408	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00038	0.000391	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.000375	0.000386	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000373	0.000384	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.00037	0.000381	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.00037	0.000381	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.000369	0.00038	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000365	0.000376	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000359	0.000369	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000357	0.000368	CbGpPWpGaD
Metixene—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000356	0.000367	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000354	0.000364	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	0.000314	0.000323	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.00031	0.000319	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	0.000301	0.00031	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000267	0.000275	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000267	0.000274	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000264	0.000272	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	0.000264	0.000272	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	0.000253	0.00026	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	0.000245	0.000252	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000212	0.000218	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000211	0.000217	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000209	0.000215	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	0.000206	0.000212	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000178	0.000183	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000177	0.000183	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000176	0.000181	CbGpPWpGaD
